Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xtg-AD Mouse Model of Alzheimers Disease
The system boosts GLP-1 production by directly stimulating GLP-1 pathways and optimizing the gut microbiome for short-chain fatty acid production
Always consult with a qualified healthcare provider before starting any new supplement, especially if you are pregnant, nursing, taking medications, or have an underlying medical condition.
Optimal results are usually observed after completing the recommended number of sessions and allowing the body sufficient time to eliminate the dissolved fat
The same safety recommendations with name-brand GLP-1s apply to compounded versions
This mechanism has been validated in RCTs in populations including older adults, hemodialysis patients, and schizophrenia patients on maintenance medication